Journey Medical (DERM) Accumulated Expenses: 2020-2025
Historic Accumulated Expenses for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $21.2 million.
- Journey Medical's Accumulated Expenses rose 32.39% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year increase of 32.39%. This contributed to the annual value of $17.4 million for FY2024, which is 14.37% down from last year.
- Per Journey Medical's latest filing, its Accumulated Expenses stood at $21.2 million for Q3 2025, which was down 6.03% from $22.6 million recorded in Q2 2025.
- Journey Medical's Accumulated Expenses' 5-year high stood at $26.0 million during Q3 2021, with a 5-year trough of $16.0 million in Q2 2024.
- In the last 3 years, Journey Medical's Accumulated Expenses had a median value of $20.0 million in 2024 and averaged $19.4 million.
- Its Accumulated Expenses has fluctuated over the past 5 years, first slumped by 32.88% in 2023, then surged by 41.21% in 2025.
- Journey Medical's Accumulated Expenses (Quarterly) stood at $22.7 million in 2021, then dropped by 14.71% to $19.4 million in 2022, then rose by 4.96% to $20.4 million in 2023, then decreased by 14.37% to $17.4 million in 2024, then surged by 32.39% to $21.2 million in 2025.
- Its last three reported values are $21.2 million in Q3 2025, $22.6 million for Q2 2025, and $23.0 million during Q1 2025.